| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.23 | 0.0006 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.004 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.46 | 0.005 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.15 | 0.005 |